Spots Global Cancer Trial Database for liver and intrahepatic biliary tract cancer
Every month we try and update this database with for liver and intrahepatic biliary tract cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer | NCT00903396 | Anal Cancer Carcinoma of th... Colorectal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Gastrointestina... Liver Cancer Nausea and Vomi... Pancreatic Canc... Primary Periton... Small Intestine... | palonosetron hy... placebo | 18 Years - | Alliance for Clinical Trials in Oncology | |
| DX-8951f in Treating Patients With Biliary Cancer | NCT00005938 | Extrahepatic Bi... Gallbladder Can... Liver Cancer | exatecan mesyla... | 16 Years - | Daiichi Sankyo | |
| Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer | NCT00658593 | Extrahepatic Bi... Gallbladder Can... Liver Cancer | capecitabine gemcitabine hyd... quality-of-life... | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer | NCT00658593 | Extrahepatic Bi... Gallbladder Can... Liver Cancer | capecitabine gemcitabine hyd... quality-of-life... | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery | NCT01313377 | Extrahepatic Bi... Gallbladder Can... Liver Cancer | gemcitabine hyd... oxaliplatin clinical observ... adjuvant therap... quality-of-life... | 18 Years - 120 Years | UNICANCER | |
| DX-8951f in Treating Patients With Biliary Cancer | NCT00005938 | Extrahepatic Bi... Gallbladder Can... Liver Cancer | exatecan mesyla... | 16 Years - | Daiichi Sankyo | |
| Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer | NCT02293954 | Breast Cancer Colon Cancer Extrahepatic Bi... Gallbladder Can... Gastrointestina... Liver and Intra... Lung Cancer Metastatic Canc... Pancreatic Canc... Rectal Cancer Thyroid Gland M... Unspecified Adu... | radionuclide im... positron emissi... laboratory biom... pharmacological... Cu 64 anti-CEA ... | 18 Years - | City of Hope Medical Center | |
| DX-8951f in Treating Patients With Biliary Cancer | NCT00005938 | Extrahepatic Bi... Gallbladder Can... Liver Cancer | exatecan mesyla... | 16 Years - | Daiichi Sankyo | |
| Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery | NCT01313377 | Extrahepatic Bi... Gallbladder Can... Liver Cancer | gemcitabine hyd... oxaliplatin clinical observ... adjuvant therap... quality-of-life... | 18 Years - 120 Years | UNICANCER |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
